Special ReportProteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation★
Section snippets
Preamble
Considerable evidence, accrued over the past decade, indicates that the presence of even relatively small amounts of protein or albumin in the urine is an important early sign of kidney disease and is a strong predictor of an increased risk for cardiovascular mortality and morbidity in certain high-risk groups within the general population. The early detection of proteinuria/albuminuria and institution of appropriate therapy has been shown to slow the progression of kidney disease. Similarly,
Background
Increased urinary protein or albumin excretion (microalbuminuria) is a cardinal sign and an independent risk factor or predictor for the outcome of both kidney and cardiovascular disease (Table 1 gives definitions and indications for testing).Proteinuria may be detected as part of a routine examination or in association with other signs and symptoms of generalized or systemic illness.
Occasionally, proteinuria/microalbuminuria may be transient, for example, as a result of upright position
Proteinuria and cardiovascular disease
The presence of small quantities of albumin in the urine (microalbuminuria) in high-risk individuals (diabetic, obese, hypertensive, family history of cardiovascular or renal disease) is now recognized as an independent risk factor or predictor of cardiovascular disease (heart attack, stroke). Microalbuminuria itself does not cause cardiovascular disease. Rather, its presence signals and identifies those individuals who will need more intensive therapy and closer follow-up. Thus, these patients
Proteinuria and progressive kidney disease
In a variety of studies, proteinuria has been identified as an important and independent risk factor for the progression of renal disease. The magnitude of proteinuria is also directly correlated with risk for end-stage renal disease and the rate of progression to renal failure. The greater the magnitude of proteinuria, the faster is the loss of renal function. In addition, at any given level of proteinuria, the higher the blood pressure, the more detrimental is the effect of proteinuria on
Proteinuria in the nephrotic syndrome
Although the detrimental effects of proteinuria begin at relatively modest levels of protein excretion, the urinary loss of massive amounts of protein presents a special problem. Massive proteinuria (nephrotic-range proteinuria) is defined in the adult patient when urinary excretion is greater than 3 g protein/24 h and in children when urinary protein excretion exceeds 1 g/m2 body surface area/24 h. Most of these individuals will manifest 3+ to 4+ proteinuria by urinary dipstick measurements.
Nephrology referral and follow-up
Patients with persistent proteinuria will benefit from consultation with a nephrologist. Nephrology evaluation of the patient with persistent proteinuria is likely to include estimation of glomerular filtration rate (eg, creatinine clearance), urine microscopic evaluation, renal ultrasound, serological testing for systemic disorders that can cause proteinuria (eg, hepatitis, antinuclear antibody, human immunodeficiency virus), and measurement of complement levels. A diagnostic kidney biopsy may
NKF PARADE committee
- 1.
Co-Chairs: Garabed Eknoyan, MD William F. Keane, MD
- 2.
Microalbuminuria and Cardiovascular Disease Committee Members: Richard Grimm, MD, and Ronald Portman, MD—Co-Chairs Bruce Culleton, MD, John M. Flack, MD, MPH, James Sowers, MD
- 3.
Proteinuria and Progression of Renal Disease Committee Members: Lee Hebert, MD, and Ronald Hogg, MD—Co-Chairs Lawrence Agodoa, MD, Allison Eddy, MD, Lawrence Hunsicker, MD, Bertram Kasiske, MD, Shaul Massry, MD, Dawn Milliner, MD, Giuseppe Remuzzi, MD
- 4.
Proteinuria and
References (0)
Cited by (501)
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
2024, Kidney International
Received and accepted as submitted January 29, 1999.
Address reprint requests to Kerry Willis, PhD, National Kidney Foundation, 30 E 33rd St, New York, NY 10016. E-mail: [email protected]
- ★
See page 1009 for a list of Committee members.